Patents by Inventor Christopher Darrow

Christopher Darrow has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7076092
    Abstract: A method and apparatus with the sensitivity to detect and identify single target molecules through the localization of dual, fluorescently labeled probe molecules. This can be accomplished through specific attachment of the taget to a surface or in a two-dimensional (2D) flowing fluid sheet having approximate dimensions of 0.5 ?m×100 ?m×100 ?m. A device using these methods would have 103–104 greater throughput than previous one-dimensional (1D) micro-stream devices having 1 ?m3 interrogation volumes and would for the first time allow immuno- and DNA assays at ultra-low (femtomolar) concentrations to be performed in short time periods (˜10 minutes). The use of novel labels (such as metal or semiconductor nanoparticles) may be incorporated to further extend the sensitivity possibly into the attomolar range.
    Type: Grant
    Filed: June 12, 2002
    Date of Patent: July 11, 2006
    Assignee: The United States of America as represented by the United States Department of Energy
    Inventors: Christopher W. Hollars, Thomas R. Huser, Stephen M. Lane, Rodney L. Balhorn, Olgica Bakajin, Christopher Darrow, Joe H. Satcher, Jr.
  • Publication number: 20060062440
    Abstract: A method and apparatus with the sensitivity to detect and identify single target molecules through the localization of dual, fluorescently labeled probe molecules. This can be accomplished through specific attachment of the taget to a surface or in a two-dimensional (2D) flowing fluid sheet having approximate dimensions of 0.5 ?m×100 ?m×100 ?m. A device using these methods would have 103-104 greater throughput than previous one-dimensional (1D) micro-stream devices having 1 ?m3 interrogation volumes and would for the first time allow immuno- and DNA assays at ultra-low (femtomolar) concentrations to be performed in short time periods (˜10 minutes). The use of novel labels (such as metal or semiconductor nanoparticles) may be incorporated to further extend the sensitivity possibly into the attomolar range.
    Type: Application
    Filed: June 12, 2002
    Publication date: March 23, 2006
    Inventors: Christopher Hollars, Thomas Huser, Stephen Lane, Rodney Balhorn, Olgica Bakajin, Christopher Darrow, Joe Satcher